SEC Comment Letter 0000000000-24-011647 to TAO Synergies Inc. (TAOX)
TAO Synergies Inc.
Date: Oct. 16, 2024 · CIK: 0001571934 · Accession: 0000000000-24-011647
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282589
Letter
October 16, 2024 Alan Tuchman Chief Executive Officer Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York, NY 10036 Re:Synaptogenix, Inc. Registration Statement on Form S-3 Filed October 10, 2024 File No. 333-282589 Dear Alan Tuchman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Daniel Bagliebter
Show Raw Text
October 16, 2024
Alan Tuchman
Chief Executive Officer
Synaptogenix, Inc.
1185 Avenue of the Americas, 3rd Floor
New York, NY 10036
Re:Synaptogenix, Inc.
Registration Statement on Form S-3
Filed October 10, 2024
File No. 333-282589
Dear Alan Tuchman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Daniel Bagliebter